Cargando…

Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB study

BACKGROUND: In the REMoxTB study of 4-month treatment-shortening regimens containing moxifloxacin compared to the standard 6-month regimen for tuberculosis, the proportion of unfavourable outcomes for women was similar in all study arms, but men had more frequent unfavourable outcomes (bacteriologic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murphy, M. E., Wills, G. H., Murthy, S., Louw, C., Bateson, A. L. C., Hunt, R. D., McHugh, T. D., Nunn, A. J., Meredith, S. K., Mendel, C. M., Spigelman, M., Crook, A. M., Gillespie, S. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192317/ https://www.ncbi.nlm.nih.gov/pubmed/30326959 http://dx.doi.org/10.1186/s12916-018-1169-5

Ejemplares similares

Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study
por: Tweed, Conor Duncan, et al.
Publicado: (2018)

Toxicity associated with tuberculosis chemotherapy in the REMoxTB study
por: Tweed, Conor D., et al.
Publicado: (2018)

Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status
por: Tweed, Conor D., et al.
Publicado: (2019)

A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens
por: Phillips, Patrick P. J., et al.
Publicado: (2017)

A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB
por: Tweed, C. D., et al.
Publicado: (2021)

Spot sputum samples are at least as good as early morning samples for identifying Mycobacterium tuberculosis
por: Murphy, Michael E., et al.
Publicado: (2017)

Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts
por: Oelofse, S., et al.
Publicado: (2021)

Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis
por: Murthy, S. E., et al.
Publicado: (2018)

Bedaquiline, pretomanid and linezolid for treatment of extensively drug resistant, intolerant or non-responsive multidrug resistant pulmonary tuberculosis
por: Conradie, Francesca, et al.
Publicado: (2020)

Erratum to: Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials
por: Phillips, Patrick P. J., et al.
Publicado: (2016)

Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trials
por: Phillips, Patrick P. J., et al.
Publicado: (2016)

World TB Day 2016: an interview with leading experts in tuberculosis research
por: Phillips, Patrick P. J., et al.
Publicado: (2016)

Investigation of the efficacy of the short regimen for rifampicin-resistant TB from the STREAM trial
por: Phillips, P. P. J., et al.
Publicado: (2020)

COVID-19 vaccine development: What lessons can we learn from TB?
por: Safar, Hussain A., et al.
Publicado: (2020)

Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study
por: Bryant, Josephine M, et al.
Publicado: (2013)

Quality of life among tuberculosis (TB), TB retreatment and/or TB-HIV co-infected primary public health care patients in three districts in South Africa
por: Louw, Julia, et al.
Publicado: (2012)

Use of a molecular bacterial load assay to distinguish between active TB and post-TB lung disease
por: Mbelele, P. M., et al.
Publicado: (2022)

Uniting to end the TB epidemic: advances in disease control from prevention to better diagnosis and treatment
por: Abubakar, Ibrahim, et al.
Publicado: (2016)

Linezolid resistance in patients with drug-resistant TB
por: Vengurlekar, D., et al.
Publicado: (2023)

Post-TB health and wellbeing
por: Nightingale, R., et al.
Publicado: (2023)

Daily Dosing for Bedaquiline in Patients with Tuberculosis
por: Salinger, David H., et al.
Publicado: (2019)

Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts
por: Chakaya, Jeremiah, et al.
Publicado: (2021)

TB Anywhere is TB Everywhere
por: Wortham, Jonathan M.
Publicado: (2018)

Clinical standards for drug-susceptible pulmonary TB
por: Akkerman, O. W., et al.
Publicado: (2022)

Advances in clinical trial design: Weaving tomorrow’s TB treatments
por: Lienhardt, Christian, et al.
Publicado: (2020)

TB preventive therapy preferences among children and adolescents
por: Strauss, M., et al.
Publicado: (2023)

Ascertainment Bias in TB Treatment Trials: Can Systematic Assessment of Objective Endpoints Solve It?
por: Mitnick, Carole D., et al.
Publicado: (2023)

Clinical standards for the dosing and management of TB drugs
por: Alffenaar, J. W. C., et al.
Publicado: (2022)

Superdeformed band in $^{147}$Tb
por: Nieminen, J M, et al.
Publicado: (1996)

Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants: a post-hoc analysis of the TB APPRISE trial
por: Cherkos, Ashenafi S., et al.
Publicado: (2023)

Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function
por: Allwood, B. W., et al.
Publicado: (2021)

Clinical standards for drug-susceptible TB in children and adolescents
por: Chiang, S. S., et al.
Publicado: (2023)

Cost of TB prevention and treatment in the Philippines in 2017
por: Capeding, T. P. J., et al.
Publicado: (2022)

Finding gaps in routine TB surveillance activities in Bangladesh
por: Allorant, A., et al.
Publicado: (2022)

Combination of Cytokine Responses Indicative of Latent TB and Active TB in Malawian Adults
por: Hur, Yun-Gyoung, et al.
Publicado: (2013)

Clinical standards for the management of adverse effects during treatment for TB
por: Singh, K. P., et al.
Publicado: (2023)

UNITE4TB: a new consortium for clinical drug and regimen development for TB
por: Boeree, M. J., et al.
Publicado: (2021)

An approach for improving the quality of country-level TB modelling
por: McQuaid, C. F., et al.
Publicado: (2021)

Cost of TB services: approach and summary findings of a multi-country study (Value TB)
por: Sweeney, S., et al.
Publicado: (2022)

Performance of spirometry assessment at TB diagnosis
por: Rachow, A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cda761s58lfj9um6d7melkd0k7